Betahistine
Sponsors
OBEcure Ltd., Nathan Kline Institute for Psychiatric Research, Eye & ENT Hospital of Fudan University, Seoul National University Hospital
Conditions
Autism Spectrum DisorderBipolar I DisorderBipolar IIBipolar NOS(Not Otherwise Specified)HealthyHypercholesterolemiaMeniere's DiseaseObesity
Phase 1
Evaluation of Safety, Drug-Drug Interactions and Pharmacokinetic Profiles of Co-Administration of Betahistine With Olanzapine in Healthy Female Subjects
CompletedNCT00852956
Start: 2009-02-28End: 2009-04-30Target: 50Updated: 2009-05-05
Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation
RecruitingNCT06001593
Start: 2023-09-18End: 2025-12-31Target: 120Updated: 2024-12-05
Phase 2
The Effect of Betahistine on Body Weight in Obese Subjects
CompletedNCT00409305
Start: 2007-01-31End: 2007-06-30Target: 280Updated: 2015-04-21
Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment
TerminatedNCT00428168
Start: 2007-03-31End: 2008-12-31Updated: 2015-10-15
A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin
TerminatedNCT00466869
Start: 2007-05-31End: 2007-09-30Target: 30Updated: 2007-09-26
Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain
CompletedNCT00709202
Start: 2008-07-31End: 2016-12-31Updated: 2019-01-25